| Literature DB >> 35052878 |
Andrey L Rakitin1, Yulia K Yushina2, Elena V Zaiko2, Dagmara S Bataeva2, Oksana A Kuznetsova2, Anastasia A Semenova2, Svetlana A Ermolaeva3,4, Aleksey V Beletskiy1, Tat'yana V Kolganova1, Andrey V Mardanov1, Sergei O Shapovalov5, Timofey E Tkachik5.
Abstract
Food products may be a source of Salmonella, one of the main causal agents of food poisoning, especially after the emergence of strains resistant to antimicrobial preparations. The present work dealt with investigation of the occurrence of resistance to antimicrobial preparations among S. enterica strains isolated from food. The isolates belonged to 11 serovars, among which Infantis (28%), Enteritidis (19%), and Typhimurium (13.4%) predominated. The isolates were most commonly resistant to trimethoprim/sulfamethoxazole (n = 19, 59.38%), cefazolin (n = 15, 46.86%), tetracycline (n = 13, 40.63%), and amikacin (n = 9, 28.13%). Most of the strains (68.75%) exhibited multiple resistance to commonly used antibiotics. High-throughput sequencing was used to analyse three multidrug-resistant strains (resistant to six or more antibiotics). Two of them (SZL 30 and SZL 31) belonged to S. Infantis, while one strain belonged to S. Typhimurium (SZL 38). Analysis of the genomes of the sequenced strains revealed the genes responsible for antibiotic resistance. In the genomes of strains SZL 30 and SZL 31 the genes of antibiotic resistance were shown to be localized mostly in integrons within plasmids, while most of the antibiotic resistance genes of strain SZL 38 were localized in a chromosomal island (17,949 nt). Genomes of the Salmonella strains SZL 30, SZL 31, and SZL 38 were shown to contain full-size pathogenicity islands: SPI-1, SPI-2, SPI-4, SPI-5, SPI-9, SPI-11, SPI-13, SPI-14, and CS54. Moreover, the genome of strain SZL 38 was also found to contain the full-size pathogenicity islands SPI-3, SPI-6, SPI-12, and SPI-16. The emergence of multidrug-resistant strains of various Salmonella serovars indicates that further research on the transmission pathways for these genetic determinants and monitoring of the distribution of these microorganisms are necessary.Entities:
Keywords: Salmonella; WGS; antimicrobial resistance; foodborne pathogen; serotype
Year: 2021 PMID: 35052878 PMCID: PMC8773070 DOI: 10.3390/antibiotics11010001
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Prevalence of Salmonella isolated from food products.
| Sample Type | Number of Samples Analysed | Number of Positive Samples (%) |
|---|---|---|
| Poultry | 112 | 12 (10.7) |
| Pork | 91 | 3 (3.3) |
| Beef | 103 | 7 (6.8) |
| Minced meat | 168 | 10 (6) |
| Total | 474 | 32 (6.8) |
Figure 1(A) Frequency of occurrence of Salmonella serotypes (n = 32). All isolates belonged to 11 serovars. The share (%) of each serovar is represented as a ring diagram. (B) Categories of serogroups based on the serovars. Serogroup C1: Rissen and Infantis. Serogroup B: Derby, Typhimurium, Indiana, and Reading. Serogroup D1: Enteritidis. Serogroup C2–C3: Kentucky. Serogroup G: Idikan. Serogroup E1: Give.
Antimicrobial resistance of Salmonella isolated from food products.
| Antimicrobial Class | Antimicrobial Agent | No. of Strains (%) | ||
|---|---|---|---|---|
| Resistant (R) | Intermediate (I) | Susceptible (S) | ||
| Penicillins | Ampicillin (AMP) | 8 (25.00) | 8 (3.13) | 23 (71.88) |
| Monobactams/carbapenems | Imipenem (IPM) | 6 (18.75) | 2 (6.25) | 24 (75.00) |
| Aminoglycosides | Amikacin (AMK) | 9 (28.13) | 14 (43.75) | 9 (28.13) |
| Streptomycin (STR) | 8 (25.00) | 4 (12.50) | 20 (62.50) | |
| Tobramycin | 5 (15.63) | 1 (3.13) | 26 (81.25) | |
| Cephems | Cefotaxime (CTX) | 6 (18.75) | 6 (18.75) | 20 (62.50) |
| Cefazolin (CFZ) | 15 (46.86) | 8 (25.00) | 9 (28.13) | |
| Folate pathway antagonists | Trimethoprim/ | 19 (59.38) | 0 (0) | 13 (40.63) |
| Chloramphenicol (CHL) | 7 (21.88) | 3 (9.38) | 22 (68.75) | |
| Macrolides and azalides | Azithromycin | 12 (37.50) | - | 20 (62.50) |
| β-Lactam/β-lactamase inhibitor combinations | Amoxicillin–clavulanic acid (AMC) | 2 (6.25) | 0 (0) | 30 (93.75) |
| Nitrofuran | Furadonin | 5 (18.75) | 3 (9.38) | 24 (75.00) |
| Tetracyclines | Tetracycline (TET) | 13 (40.63) | 9 (28.13) | 10 (31.25) |
Keys: ampicillin (AMP) 10 µg, imipenem (IPM) 10 µg, amikacin (AMK) 10 µg, streptomycin (STR) 10 µg, tobramycin 10 µg, cefotaxime (CTX) 30 µg, cefazolin (CFZ) 30 µg, trimethoprim/sulfamethoxazole (SXT) 1.25/23.75 µg, chloramphenicol 30 µg, azithromycin 15 µg, amoxicillin–clavulanic acid (AMC) 20/10 µg, furadonin 300 µg, and tetracycline (TET) 30 µg.
Resistance of various Salmonella strains to antimicrobial preparations.
| Antimicrobial Agent | No. of Resistance Isolates by Serotype (Resistance Rate, %) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | ||||||||||||
| Ampicillin (AMP) | 25.0 | 16.7 | 33.3 | 0.0 | 50.0 | 0.0 | 100.0 | 0.0 | 0.0 | 100.0 | 0.0 | 25.0 |
| Imipenem (IPM) | 25.0 | 16.7 | 33.3 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.8 |
| Amikacin (AMK) | 0.0 | 16.7 | 33.3 | 0.0 | 50.0 | 66.7 | 0.0 | 50.0 | 0.0 | 100.0 | 0.0 | 28.1 |
| Streptomycin (STR) | 75.0 | 0.0 | 33.3 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 100.0 | 0.0 | 25 |
| Tobramycin (TM) | 25.0 | 0.0 | 22.2 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 100.0 | 0.0 | 15.6 |
| Cefotaxime (CFX) | 25.0 | 33.3 | 11.1 | 0.0 | 0.0 | 33.3 | 0.0 | 50.0 | 0.0 | 0.0 | 0.0 | 18.8 |
| Cefazolin (CFZ) | 50.0 | 50.0 | 44.4 | 50.0 | 50.0 | 66.7 | 100.0 | 50.0 | 0.0 | 0.0 | 0.0 | 50 |
| Trimethoprim/sulfamethoxazole (STX) | 75.0 | 50.0 | 66.7 | 50.0 | 50.0 | 33.3 | 100.0 | 50.0 | 0.0 | 100.0 | 100.0 | 59.34 |
| Chloramphenicol (CHL) | 25.0 | 16.7 | 44.4 | 0.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.9 |
| Azithromycin (AZM) | 50.0 | 33.3 | 22.2 | 0.0 | 50.0 | 33.3 | 0.0 | 50.0 | 100.0 | 0.0 | 100.0 | 34.4 |
| Amoxicillin + clavulanic acid (AMK) | 0.0 | 0.0 | 22.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.3 |
| Nitrofurantoin (NIT) | 0.0 | 0.0 | 44.4 | 0.0 | 0.0 | 33.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.6 |
| Tetracycline (TET) | 75.0 | 33.3 | 55.6 | 0.0 | 0.0 | 33.3 | 0.0 | 50.0 | 0.0 | 100.0 | 0.0 | 40.6 |
Phenotypic antibiotic resistance profiles of Salmonella serotypes.
| Serovar | Isolate | Pattern | No. of Antimicrobial Agents | No. of Classes |
|---|---|---|---|---|
| S1 | AMP-STX-CFZ | 3 | 3 | |
| S3 | STR-AMP-TM-IPM-CHL | 5 | 4 | |
| S5 | CTX-STX-AZM-TET-CFZ | 5 | 4 | |
| S14 | STR-STX-AZM-TET-CFZ | 5 | 4 | |
| S25 | STR-STX-TET | 3 | 3 | |
| S23 | CTX-AMK-AZM-CFZ | 4 | 3 | |
| S4 | AMK-STX-AZM-TET-NIT | 5 | 5 | |
| S33 | CFZ | 1 | 1 | |
| S6 | STR-AMK-AZM-TET | 4 | 3 | |
| S11 | CTX-TM-STX-CFZ | 4 | 3 | |
| S9 | AZM | 1 | 1 | |
| S10 | CFZ-CHL | 1 | 1 | |
| S18 | AMP-AMK-STX-AZM | 4 | 4 | |
| S26 | STR-IPM-CFZ-NIT | 4 | 4 | |
| S15 | AMK-STX-AZM-TET-CFZ | 5 | 5 | |
| SZL 30 | STR-AMP-AMK-TM-STX-IPM-TET-CHL | 8 | 6 | |
| SZL 31 | STR-AMP-AMK-TM-STX-IPM-TET-CHL | 8 | 6 | |
| S34 | AMK-STX-TET-CFZ-NIT | 5 | 5 | |
| S35 | STX | 1 | 1 | |
| S36 | ND | 0 | 0 | |
| S37 | STX-TET-NIT | 3 | 3 | |
| S28 | CTX-AZM-CFZ-CHL-NIT | 5 | 4 | |
| S16 | STX-AZM | 2 | 2 | |
| S7 | AMK-AZM-CFZ | 3 | 3 | |
| S8 | CTX-AZM | 2 | 2 | |
| S17 | AMP-STX-TET-CFZ-CHL | 5 | 5 | |
| S20 | STX-IPM-CFZ | 3 | 3 | |
| S27 | CTX-TET | 2 | 2 | |
| S29 | STX | 1 | 1 | |
| S32 | ND | 0 | 0 | |
| S19 | STX-IMP-CFZ | 3 | 3 | |
| SZL 38 | STR-AMP-AMK-TM-STX-TET | 6 | 4 |
Keys: ampicillin (AMP) 10 µg, imipenem (IPM) 10 µg, amikacin (AMK) 10 µg, streptomycin (STR) 10 µg, tobramycin 10 µg, cefotaxime (CTX) 30 µg, cefazolin (CFZ) 30 µg, trimethoprim/sulfamethoxazole (SXT) 1.25/23.75 µg, chloramphenicol 30 µg, azithromycin 15 µg, amoxicillin–clavulanic acid (AMC) 20/10 µg, furadonin 300 µg, and tetracycline (TET) 30 µg.
Genomes of the Salmonella strains.
| Strain | Chromosome Size (bp) | Plasmids | |
|---|---|---|---|
| Name | Size (bp) | ||
| SZL 30 | 4,689,375 | pSZL30.1 | 276,251 |
| SZL 31 | 4,689,704 | pSZL31.1 | 280,239 |
| SZL 38 | 5,052,615 | pSZL38.1 | 79,333 |
General characteristics of the Salmonella genomes.
| Parameter | Strain | ||
|---|---|---|---|
| 30 | 31 | 38 | |
| Predicted genes | 5184 | 5191 | 5320 |
| Protein-coding genes | 5078 | 5085 | 5209 |
| Protein-coding genes with | 3845 | 3785 | 3851 |
| tRNA genes | 84 | 84 | 89 |
Antibiotic resistance genes in the Salmonella genomes.
| Resistance Gene | Protein | Antimicrobial Agent | Location | ||
|---|---|---|---|---|---|
| SZL 30 | SZL 31 | SZL 38 | |||
|
| Aminoglycoside (3″) (9)-adenylyltransferase | STR | pSZL30.2 | - | - |
|
| - | pSZL31.1 | - | ||
|
| Aminoglycoside 3′-phosphotransferase | - | - | chromosome | |
|
| Aminoglycoside O-phosphotransferase | - | - | chromosome | |
|
| Class A β-lactamase | AMP | pSZL30.2 | pSZL31.2 | chromosome |
|
| Chromosomal encoded aminoglycoside N (6′)-acetyltransferase | AMK, TM | chromosome | chromosome | chromosome |
|
| Dihydropteroate synthase | STX | pSZL30.2 | pSZL31.1 | - |
|
| - | - | chromosome | ||
|
| Tetracycline efflux MSF transporter | TET | pSZL30.1 | pSZL31.1 | - |
|
| - | - | chromosome | ||
|
| Drug efflux MSF transporter Bcr/CflA family | CHL | pSZL30.2 | pSZL31.1 | - |
|
| MSF efflux transporter | AZM, ERY | pSZL30.2 | chromosome pSZL31.2 | - |
|
| MSF efflux transporter | RIF, PUR, ERY | chromosome | chromosome | chromosome |
| MSF efflux transporter | NB, NAL, NOR | chromosome | chromosome | chromosome | |
Figure 2(A) Diagram of type I integrons and their flanking regions found in plasmids pSZL31.1, pSZL31.2, and pSZL30.2. (B) Schematic of type II integrons found in plasmids pSZL31.1 and pSZL30.1. (C) An island of resistance located on the chromosome of Salmonella S38. Red arrows indicate genes for resistance; orange genes are involved in the mobile transfer of genetic material. aadA1, aadA2b, aph(3″)-Ib, and aph(6)-Id—genes for streptomycin resistance, bla—ampicillin resistance gene, cmlA1—chloramphenicol resistance gene, dfrA14—trimethoprim resistance gene, mefB—gene for resistance to macrolide antibiotics, qacH—gene for resistance to quaternary ammonium compounds, sul2 and sul3—genes for resistance to sulfamethoxazole, sat1—gene for resistance to streptothricin, tetA and tetB—genes for resistance to tetracycline, tetR—transcription regulator of genes tetA and tetB. merRTPCADE—mercury resistance operon. intl1 and intl2—integrases, IS26 and IS1R—insertion elements, orf1, orf2, orf3, and orf4—genes coding proteins with unknown function, sdr—short chain dehydrogenase, repA and repC—replication proteins, tnpTn21—transposase. ΔIS440, ΔtetC, ΔtnpM, and ΔresTn3—different variants of insertion element, transcription regulator, transposase, and resolvase, respectively.